Us Study Finds Astrazeneca Covid-19 Vaccine Effective, Doesn't Increase Blood Clot Risk
22 March 2021
AstraZeneca's COVID-19 vaccine showed 79 percent efficacy against symptomatic disease and 100 percent efficacy against severe disease and hospitalization in a new, US-based cli...